VCM
CGON icon

Versant Capital Management’s CG Oncology CGON Stock Holding History

Versant Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.77K Hold
39
– – ﹤0.01% 2562
2026
Q2 		$2.77K Hold
39
– – ﹤0.01% 2521
2026
Q1 		$2.64K Hold
39
– – ﹤0.01% 2518
2025
Q4 		$1.62K Hold
39
– – ﹤0.01% 2469
2025
Q3 		$1.57K Hold
39
– – ﹤0.01% 2447
2025
Q2 		$1.01K Buy
39
+26
+200% +$627 ﹤0.01% 2485
2025
Q1 		$318 Sell
13
-400
-97% -$11.3K ﹤0.01% 2441
2024
Q4 		$11.8K Buy
+413
New +$14.1K ﹤0.01% 1313

Other funds holding CGON

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Versant Capital Management's CGON Position: Q3 2026 in Review

Versant Capital Management held its CG Oncology (CGON) position steady in Q3 2026 at 39 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

Versant Capital Management first reported a position in CGON in Q4 2024 and has held it in 8 quarters since. The position peaked at $11.8K in Q4 2024. 8 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • Versant Capital Management held 39 shares of CG Oncology worth $2.77K as of Q3 2026.
  • Versant Capital Management left its CG Oncology share count unchanged in Q3 2026.
  • CG Oncology made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2562 holding.
  • Versant Capital Management first reported a position in CG Oncology in Q4 2024 and has held it in 8 quarters since.
  • Versant Capital Management's CG Oncology position peaked at $11.8K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.